Shares of Pharma Mar (OTCMKTS:PHMMF – Get Free Report) gapped up before the market opened on Monday. The stock had previously closed at $70.70, but opened at $75.05. Pharma Mar shares last traded at $75.05, with a volume of 100 shares trading hands.
Pharma Mar Trading Up 1.6%
The firm’s 50-day moving average price is $91.48 and its two-hundred day moving average price is $92.89.
Pharma Mar Company Profile
Pharma Mar, SA is a Spanish biopharmaceutical company focused on discovering, developing and commercializing innovative medicines derived from marine organisms. The company specializes primarily in oncology and maintains a research platform dedicated to identifying novel compounds with potential anticancer activity.
Its principal products include Yondelis (trabectedin), an anticancer treatment used in certain cases of advanced soft-tissue sarcoma and ovarian cancer, and Zepzelca (lurbinectedin), a therapy developed for patients with metastatic small-cell lung cancer whose disease has progressed during or after platinum-based chemotherapy.
Read More
- Five stocks we like better than Pharma Mar
- Want to Escape the AI Sell-Off? This ETF Offers a Surprising Alternative
- America’s Rare Earth Clock Is Running Out, But the Bottleneck Isn’t Where You Think
- Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
